Iovance Biotherapeutics, Inc.
IOVA- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
近 90 天,Iovance Biotherapeutics, Inc. 沒有內部人公開市場買賣的申報;2026 年第 2 季末有 293 家機構在 13F 申報持有,市值合計 $11.9 億;沒有大師持有。
SEC 申報
Iovance Biotherapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F,最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀;8-K 的新聞稿等附件(例如 Item 2.02 的 EX-99.1)在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/5 | 8-K | 8.019.01 | 2026/11/5 | SEC | 目錄 |
| 2026/11/5 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/5 | 8-K | 2.029.01 | 2026/11/5 | SEC | 目錄 |
| 2026/10/29 | 8-K | 8.019.01 | 2026/10/29 | SEC | 目錄 |
| 2026/10/5 | 8-K | 8.019.01 | 2026/10/5 | SEC | 目錄 |
| 2026/9/29 | 8-K | 8.019.01 | 2026/9/29 | SEC | 目錄 |
| 2026/8/6 | 8-K | 8.019.01 | 2026/8/6 | SEC | 目錄 |
| 2026/8/6 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/6 | 8-K | 2.029.01 | 2026/8/6 | SEC | 目錄 |
| 2026/7/2 | 8-K | 8.019.01 | 2026/6/30 | SEC | 目錄 |
| 2026/6/10 | 8-K | 5.078.019.01 | 2026/6/4 | SEC | 目錄 |
| 2026/5/7 | 8-K | 2.029.01 | 2026/5/7 | SEC | 目錄 |
| 2026/5/7 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/3/20 | 8-K | 5.02 | 2026/3/17 | SEC | 目錄 |
| 2026/2/24 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/2/24 | 8-K | 2.028.019.01 | 2026/2/24 | SEC | 目錄 |
| 2026/1/9 | 8-K | 8.019.01 | 2026/1/9 | SEC | 目錄 |
| 2025/11/6 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/6 | 8-K | 2.029.01 | 2025/11/6 | SEC | 目錄 |
| 2025/8/29 | 8-K | 8.019.01 | 2025/8/29 | SEC | 目錄 |
| 2025/8/22 | 8-K | 1.019.01 | 2025/8/22 | SEC | 目錄 |
| 2025/8/19 | 8-K | 8.019.01 | 2025/8/18 | SEC | 目錄 |
| 2025/8/7 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/7 | 8-K | 2.025.029.01 | 2025/8/7 | SEC | 目錄 |
| 2025/7/15 | 8-K | 5.028.019.01 | 2025/7/15 | SEC | 目錄 |
| 2025/7/3 | 8-K | 5.02 | 2025/6/30 | SEC | 目錄 |
| 2025/6/13 | 8-K | 5.02 | 2025/6/10 | SEC | 目錄 |
| 2025/6/10 | 8-K | 5.07 | 2025/6/10 | SEC | 目錄 |
| 2025/5/8 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/8 | 8-K | 2.029.01 | 2025/5/8 | SEC | 目錄 |
| 2025/2/27 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/27 | 8-K | 2.029.01 | 2025/2/27 | SEC | 目錄 |
| 2025/2/10 | 8-K | 8.019.01 | 2025/2/10 | SEC | 目錄 |
| 2024/11/21 | 8-K | 1.011.02 | 2024/11/15 | SEC | 目錄 |
| 2024/11/8 | 8-K | 8.019.01 | 2024/11/7 | SEC | 目錄 |
| 2024/11/7 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/7 | 8-K | 2.029.01 | 2024/11/7 | SEC | 目錄 |
| 2024/8/9 | 8-K | 8.019.01 | 2024/8/8 | SEC | 目錄 |
| 2024/8/8 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/8 | 8-K | 2.029.01 | 2024/8/8 | SEC | 目錄 |
| 2024/6/28 | 8-K | 8.019.01 | 2024/6/28 | SEC | 目錄 |
| 2024/6/11 | 8-K | 5.07 | 2024/6/11 | SEC | 目錄 |
| 2024/6/3 | 8-K | 8.019.01 | 2024/5/31 | SEC | 目錄 |
| 2024/5/24 | 8-K | 8.019.01 | 2024/5/23 | SEC | 目錄 |
| 2024/5/9 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/9 | 8-K | 2.029.01 | 2024/5/9 | SEC | 目錄 |
| 2024/4/3 | 8-K | 8.019.01 | 2024/4/3 | SEC | 目錄 |
| 2024/3/29 | 8-K | 5.025.039.01 | 2024/3/26 | SEC | 目錄 |
| 2024/3/4 | 8-K | 8.019.01 | 2024/3/4 | SEC | 目錄 |
| 2024/2/29 | 8-K | 8.019.01 | 2024/2/28 | SEC | 目錄 |